Browse drugs

…sponding cells with significant PD-1 decrease when treated with MAGE. Interestingly, the carrier protein (MB) also showed significan…

… senescence in BEAS-2B cells.Conclusion These data suggest that geraldol could be a novel senotherapy for the treatment of COPD or other…

…and hydroxyproline content levels in the PCLS model.Conclusions Treprostinil inhibits RhoA activation and this may be via PPARβδ activation.…

… biochemical parameters. Budesonide and prednisone were weaned. Tofacitinib continues.Conclusions CD20+ cells play a regulatory and protect…

…were mild or moderate in severity. There were no serious TEAEs. Enpatoran PK was dose proportional, with peak concentration reached 1–2 h…

…H, Houssiau F, et al. Two-year, randomized, controlled trial of belimumab in lupus nephritis. N Engl J Med. 2020;383(12):1117–28. doi: 10…

…Seladelpar is a first-in-class delpar (selective PPAR-delta agonist) indic…

…le therapies Fibrate therapy First (FIB-OCA) OCA therapy First (OCA-FIB) (FIB-OCA) and (OCA-FIB) Comparative p Values ALP M0 (n27) M6 (…

…cribed Ursodeoxycholic acid (UDCA), Obeticholic acid (OCA), and Bezafibrate (BZA), has shown biochemical benefit in patients with inadequat…

…dmission with HE 1 (8%) Pre-admission TIPS 1 (8%) Pre-admission Rifaximin 12 (92%) Pre-admission Lactulose 11 (85%) Grade HE on presentat…

…as adapted for this study. Treatments (phosphate buffer saline, dexamethasone, SR-COL, ROPI or PKM-01) were administered intra-articularly im…

…cer, although there remains a need for improvement in efficacy. Fruquintinib, an oral and highly selective vascular endothelial growth facto…